Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-21-058609

Chief Scientific Officer sold 1,364 shares at $19.26 ($26,265)

  • Chief Scientific Officer acquired 8,125 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Vig Pamela · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-29 Grant or award : show line 1 in the form +8,125 11,031 D
2021-10-01 Sale : show line 2 in the form −1,364 $19.26 $26,265 9,667 D
Open-market sales · 1,364 sh · avg $19.26 · $26,265
Loading xslF345X03/doc4.xml…